Welcome to our dedicated page for Trimas SEC filings (Ticker: TRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to TriMas Corporation (NASDAQ: TRS) SEC filings, giving investors a detailed view of how the company reports its operations in the consumer products, aerospace and industrial markets. TriMas files a range of documents with the U.S. Securities and Exchange Commission, including annual and quarterly reports and current reports on Form 8‑K.
Current reports (Form 8‑K) are particularly important for tracking significant events. For example, on July 29, 2025 and October 28, 2025, TriMas filed Forms 8‑K to furnish press releases reporting its second and third quarter 2025 financial results. These filings reference segment performance for TriMas Packaging, TriMas Aerospace and Specialty Products, and provide context on non‑GAAP metrics such as adjusted net income, adjusted diluted earnings per share, Free Cash Flow and Net Debt, with reconciliations in the accompanying materials.
On November 4, 2025, TriMas filed a Form 8‑K describing an Equity Purchase Agreement under which certain wholly owned subsidiaries agreed to sell the company’s aerospace business segment to an affiliate of Tinicum L.P., with funds managed by Blackstone as a minority investor. The filing outlines the cash purchase price, customary adjustments, closing conditions, regulatory approvals and termination rights, offering detailed insight into this planned divestiture.
Through this page, users can review 10‑K annual reports and 10‑Q quarterly reports (when available) to understand TriMas’ segment mix, risk factors and accounting policies. These reports expand on topics referenced in news releases, such as economic and currency risks, supply chain pressures, acquisition and integration risks, international operations, ESG‑related expectations, leverage and debt covenants, and other factors that may affect results.
Stock Titan enhances these filings with AI‑powered summaries that explain key sections in plain language, highlight major changes from prior periods and point out items such as segment performance, capital allocation decisions and material agreements. Users can also monitor Form 4 insider transaction reports and other ownership‑related filings to see how directors and officers are trading TRS shares over time.
By combining real‑time EDGAR updates with AI‑generated insights, this page helps readers navigate TriMas’ regulatory disclosures, from routine earnings reports to material events like the planned sale of its aerospace segment.
TriMas Corporation signed an Equity Purchase Agreement to sell its aerospace business segment to Takeoff Buyer, Inc., an affiliate of Tinicum L.P. and Blackstone, Inc. The purchase price is approximately $1.45 billion in cash, subject to customary adjustments.
Closing is subject to conditions, including a pre-closing reorganization and receipt of requisite regulatory approvals. The agreement includes termination rights, and either party may terminate if the transaction has not occurred on or prior to May 4, 2026, which may be extended in certain circumstances. TriMas also furnished a press release announcing the signing.
TriMas (TRS) reported stronger Q3 2025 results, with net sales of $269.3 million, up from $229.4 million a year ago. Net income rose to $9.3 million ($0.23 diluted EPS) versus $2.5 million ($0.06) as operating profit improved and interest expense declined. For the nine months, sales reached $785.7 million and net income was $38.4 million ($0.94 diluted EPS).
Aerospace led growth, with Q3 sales of $103.2 million vs. $70.8 million, aided by the GMT Aerospace acquisition for $37.7 million. The Company also completed the sale of its Arrow Engine business for $21.0 million, recording a $5.4 million gain year‑to‑date.
Cash generation and balance sheet: net cash from operating activities was $75.9 million year‑to‑date; capital expenditures were $43.7 million. Long‑term debt was $407.1 million, including $400.0 million of 4.125% Senior Notes due 2029. The revolving credit facility was amended to $250.0 million maturing on 3/31/2030, with $10.9 million outstanding and $233.1 million available at quarter‑end.
The Company recorded an $8.0 million asbestos remeasurement, increasing the asbestos liability to $36.6 million, and began transitioning certain asbestos costs to excess insurance coverage. Shares outstanding were 40,642,475 as of September 30, 2025.
TriMas Corporation furnished a Form 8-K under Item 2.02 announcing it issued a press release on October 28, 2025 reporting financial results for the quarter ended September 30, 2025. The release is attached as Exhibit 99.1 and is available at www.trimas.com. The company states the information in Exhibit 99.1 is being furnished, not filed, and therefore is not subject to Section 18 of the Exchange Act or incorporated by reference into other filings.
Allspring Global Investments Holdings, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 2,488,390 shares of TriMas Corp common stock, representing 6.1% of the class. The filing states Allspring has sole voting power over 2,407,857 shares and sole dispositive power over 2,488,390 shares. The shares are owned of record by clients of Allspring advisers and are held in the ordinary course of business; no client is identified as holding more than 5% of the class. The filing includes a subsidiary list naming Allspring Global Investments, LLC and Allspring Funds Management, LLC.
Trimas Corporation director Daniel P. Tredwell filed a Form 4 reporting a transaction dated 08/11/2025. The filing shows a transaction with code P, a reported price of $35.387, and a reported beneficial ownership following the transaction of 60,409.424 shares. The Form 4 also discloses 7,500 shares held indirectly by his spouse. The form was signed by an attorney-in-fact on 08/13/2025.
Trimas Corporation (TRS) filed a Form 144 reporting a proposed sale of 25,000 common shares through Wells Fargo Clearing Services with an aggregate market value of $919,012.13. The filing lists the securities exchange as Nasdaq and gives an approximate sale date of 08/13/2025.
The filing details the acquisition of the securities to be sold: 5,000 shares purchased on 10/28/2022, 10,000 shares on 03/01/2024 and 10,000 shares on 11/15/2024, with payment in cash. It also discloses recent open-market sales by Thomas A. Amato: 63,965 shares sold on 07/29/2025 for $2,241,703.40 and 13,900 shares sold on 07/31/2025 for $489,988.50. Outstanding common shares are listed as 40,641,562.
Bank of America Corporation reported beneficial ownership of 3,763,259 shares of TriMas Corporation common stock, representing 9.2% of the outstanding class on a Schedule 13G/A. The filing shows no sole voting or dispositive power and material shared voting (3,431,042) and shared dispositive (3,431,719) powers, reflecting holdings held through several wholly owned subsidiaries. The statement certifies these securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing identifies the specific BofA entities holding the positions.
Form 144 filed for TriMas Corporation (TRS) discloses that insider Thomas A. Amato plans to sell 36,705 common shares through Fidelity Brokerage on or about 31 Jul 2025 on Nasdaq. Based on the filing’s stated 40,641,562 shares outstanding, the proposed sale represents roughly 0.09 % of shares outstanding and carries an aggregate market value of ≈ $1.30 million.
The notice also lists recent insider activity: Amato sold 63,965 shares on 29 Jul 2025 for $2.24 million and 95,469 shares on 30 Jul 2025 for $3.39 million, totaling 159,434 shares (≈ 0.39 % of O/S) and ≈ $5.63 million in gross proceeds over the prior three months. All shares being sold were acquired via restricted-stock vesting between 2020-2024 and are treated as compensation, implying no cash outlay by the filer.
No adverse information about the issuer is asserted, and the filer affirms compliance with Rule 10b5-1/Rule 144 representations. While the volume is modest versus the float, consecutive sizeable sales within days could be viewed by investors as a potential negative sentiment signal from senior leadership.